Tutorials
Step 1: Confirm presence of Pseudomonas aeruginosa
Step 2: Assessment for clinical deterioration
Step 3: First line and second line treatment
Step 4: Prevent future exacerbations
Tobramycin dosing for use in non-CF bronchiectasis
IV antibiotics for the Management of Bronchiectasis in the Community
The aim of this programme is to ensure that as many patients experiencing an exacerbation of their bronchiectasis, by the infective organism Pseudomonas aeruginosa, remain at home and receive antibiotics appropriate to their requirements.
Check out the TV show and tutorials on the management of patients with bronchiectasis who are colonised with Pseudomonas aeruginosa in the community. When you are ready, navigate to the assessment to achieve the certificate against the National Welsh Standard (NWS).
TV Show: All Wales Management of Bronchiectasis in the Community
The incidence of bronchiectasis in Wales is increasing, and improving the management of exacerbations for these patients will have a big impact on their quality of life and mortality.
The right place for many patients experiencing an exacerbation of their bronchiectasis is at home; they are much safer and can be equipped to receive intravenous antibiotics at home.
An initiative in Wales to standardise the approach of managing these patients, ideally in the community, comes in the form of the All-Wales Pathway for Managing Adult non-CF Bronchiectasis Patients with Pseudomonas Aeruginosa Infection in the Community.
Mark as Understood
Guidelines
All Wales Pathway for Managing Adult non CF Bronchiectasis Patients with Pseudomonas Aeruginosa Infection in the Community |
|---|
Assessments
Management of Bronchiectasis in the Community
45-minute case-based assessment
25 multiple choice questions
80% pass mark (20 out of 25)
Unlimited retakes
On successful completion, your certificate will appear under this tab.
Undertake Assessment